Value Insider Season 1 Episode 6: How Will Market Access and Value Demonstration Evolve? (Future Outlook) [Podcast] by Kanavos, Panos G, Hartgers-Gubbels, Elisabeth Sophia, Chambers, Michael

Get full text

Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries by Apostolou, E A, Main, C A, Miracolo, A, Papadakis, K, Paparouni, K, Kanavos, P G

Get full text

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases by Taruscio, D, Morciano, C, Laricchiuta, P, Mincarone, P, Palazzo, F, Leo, CG, Sabina, S, Guarino, R, Auld, J, Sejersen, T, Gavhed, D, Ritchie, K, Hilton-Boon, M, Manson, J, Kanavos, PG, Tordrup, D, Tzouma, V, Le Cam, Y, Senecat, J, Filippini, G, Minozzi, S, Del Giovane, C, Schünemann, H, Meerpohl, JJ, Prediger, B, Schell, L, Stefanov, R, Iskrov, G, Miteva-Katrandzhieva, T, Serrano-Aguilar, P, Perestelo-Perez, L, Trujillo-Martín, MM, Pñrez-Ramos, J, Rivero-Santana, A, Brand, A, van Kranen, H, Bushby, K, Atalaia, A, Ramet, J, Siderius, L, Posada, M, Abaitua-Borda, I, Ferreira, V Alonso, Hens-Pñrez, M, Manzanares, FJ

Get full text

A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom by Angelis, A, Montibeller, G, Kanavos, P

Get full text

Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework by Angelis, A., Linch, M., Montibeller, G., Molina-Lopez, T., Zawada, A., Orzel, K., Arickx, F., Espin, J., Kanavos, P.

Get full text

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications by Ferrario, Alessandra, Arāja, Diāna, Bochenek, Tomasz, Čatić, Tarik, Dankó, Dávid, Dimitrova, Maria, Fürst, Jurij, Greičiūtė-Kuprijanov, Ieva, Hoxha, Iris, Jakupi, Arianit, Laidmäe, Erki, Löblová, Olga, Mardare, Ileana, Markovic-Pekovic, Vanda, Meshkov, Dmitry, Novakovic, Tanja, Petrova, Guenka, Pomorski, Maciej, Tomek, Dominik, Voncina, Luka, Haycox, Alan, Kanavos, Panos, Vella Bonanno, Patricia, Godman, Brian

Get full text

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference by Papatheodoridis, G., Thomas, H. C., Golna, C., Bernardi, M., Carballo, M., Cornberg, M., Dalekos, G., Degertekin, B., Dourakis, S., Flisiak, R., Goldberg, D., Gore, C., Goulis, I., Hadziyannis, S., Kalamitsis, G., Kanavos, P., Kautz, A., Koskinas, I., Leite, B. R., Malliori, M., Manolakopoulos, S., Matičič, M., Papaevangelou, V., Pirona, A., Prati, D., Raptopoulou - Gigi, M., Reic, T., Robaeys, G., Schatz, E., Souliotis, K., Tountas, Y., Wiktor, S., Wilson, D., Yfantopoulos, J., Hatzakis, A.

Get full text

Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe by Kuhlmann, A., Schmidt, T., Treskova, M., López-Bastida, J., Linertová, R., Oliva-Moreno, J., Serrano-Aguilar, P., Posada-de-la-Paz, M., Kanavos, P., Taruscio, D., Schieppati, A., Iskrov, G., Péntek, M., Delgado, C., von der Schulenburg, J. M., Persson, U., Chevreul, K., Fattore, G.

Get full text

Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United Kingdom by Morgan, Steven G, McMahon, Meghan, Mitton, Craig, Roughead, Elizabeth, Kirk, Ray, Kanavos, Panos, Menon, Devidas

Get full text

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study by Linertová, Renata, Serrano-Aguilar, Pedro, Posada-de-la-Paz, Manuel, Hens-Pérez, Manuel, Kanavos, Panos, Taruscio, Domenica, Schieppati, Arrigo, Stefanov, Rumen, Péntek, Márta, Delgado, Claudia, Graf von der Schulenburg, Johann-Matthias, Persson, Ulf, Chevreul, Karine, Fattore, Giovanni, Worbes-Cerezo, Melany, Sefton, Mark, López-Bastida, Julio

Get full text

PSY109 - Reimbursed Price of Orphan Drugs: A Value Based Framework by Mincarone, P, Leo, CG, Sabina, S, Tordrup, D, Taruscio, D, Kanavos, P

Get full text

Reimbursed Price of Orphan Drugs: A Value Based Framework by Mincarone, P, Leo, CG, Sabina, S, Tordrup, D, Taruscio, D, Kanavos, P

Get full text

Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries by Kalo, Z, Alabbadi, I, Al, Ahdab O.G, Al-Badriyeh, D, Alowayesh, M, Al-Saggabi, A.H, Elmahdawy, M, Tanzi, V.L, Alsultan, H, Akhras, K, Kanavos, P

Get full text

The role of funding and policies on innovation in cancer drug development by Kanavos, P, Sullivan, R, Lewison, G, Schurer, W, Eckhouse, S, Vlachopioti, Z

Get full text

Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: A phase II evaluation/trial by Guadagni, S, Clementi, M, Valenti, M, Fiorentini, G, Cantore, M, Kanavos, E, Caterino, G.P, Di Giuro, G, Amicucci, G

Get full text

Economic and policy issues in the pharmaceutical industry by Berndt, E R, Danzon, P M, Kruse, G B, Reiffen, D, Ward, M R, Scherer, F M, DiMasi, J A, Abbott, T A, Vernon, J A, Epstein, A, Nicholson, S, Filson, D, Masia, N, Comanor, W S, Schweitzer, S O, Virabhak, S, Pauly, M V, Philipson, T J, Grabowski, H G, Ridley, D B, Schulman, K A, Kanavos, P, Font, J C, McGuire, A, Golec, J, Lichtenberg, F R, Kyle, M, Huttin, C

Get full text